Cargando…
Dose-Dependent Risk Reduction for Myocardial Infarction with Eicosapentaenoic Acid: a Meta-analysis and Meta-regression Including the STRENGTH Trial
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452549/ https://www.ncbi.nlm.nih.gov/pubmed/34101063 http://dx.doi.org/10.1007/s10557-021-07212-z |
| _version_ | 1784570094160969728 |
|---|---|
| author | Sarajlic, Philip Artiach, Gonzalo Larsson, Susanna C. Bäck, Magnus |
| author_facet | Sarajlic, Philip Artiach, Gonzalo Larsson, Susanna C. Bäck, Magnus |
| author_sort | Sarajlic, Philip |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8452549 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84525492021-10-05 Dose-Dependent Risk Reduction for Myocardial Infarction with Eicosapentaenoic Acid: a Meta-analysis and Meta-regression Including the STRENGTH Trial Sarajlic, Philip Artiach, Gonzalo Larsson, Susanna C. Bäck, Magnus Cardiovasc Drugs Ther Letter to the Editor Springer US 2021-06-08 2021 /pmc/articles/PMC8452549/ /pubmed/34101063 http://dx.doi.org/10.1007/s10557-021-07212-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Sarajlic, Philip Artiach, Gonzalo Larsson, Susanna C. Bäck, Magnus Dose-Dependent Risk Reduction for Myocardial Infarction with Eicosapentaenoic Acid: a Meta-analysis and Meta-regression Including the STRENGTH Trial |
| title | Dose-Dependent Risk Reduction for Myocardial Infarction with Eicosapentaenoic Acid: a Meta-analysis and Meta-regression Including the STRENGTH Trial |
| title_full | Dose-Dependent Risk Reduction for Myocardial Infarction with Eicosapentaenoic Acid: a Meta-analysis and Meta-regression Including the STRENGTH Trial |
| title_fullStr | Dose-Dependent Risk Reduction for Myocardial Infarction with Eicosapentaenoic Acid: a Meta-analysis and Meta-regression Including the STRENGTH Trial |
| title_full_unstemmed | Dose-Dependent Risk Reduction for Myocardial Infarction with Eicosapentaenoic Acid: a Meta-analysis and Meta-regression Including the STRENGTH Trial |
| title_short | Dose-Dependent Risk Reduction for Myocardial Infarction with Eicosapentaenoic Acid: a Meta-analysis and Meta-regression Including the STRENGTH Trial |
| title_sort | dose-dependent risk reduction for myocardial infarction with eicosapentaenoic acid: a meta-analysis and meta-regression including the strength trial |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452549/ https://www.ncbi.nlm.nih.gov/pubmed/34101063 http://dx.doi.org/10.1007/s10557-021-07212-z |
| work_keys_str_mv | AT sarajlicphilip dosedependentriskreductionformyocardialinfarctionwitheicosapentaenoicacidametaanalysisandmetaregressionincludingthestrengthtrial AT artiachgonzalo dosedependentriskreductionformyocardialinfarctionwitheicosapentaenoicacidametaanalysisandmetaregressionincludingthestrengthtrial AT larssonsusannac dosedependentriskreductionformyocardialinfarctionwitheicosapentaenoicacidametaanalysisandmetaregressionincludingthestrengthtrial AT backmagnus dosedependentriskreductionformyocardialinfarctionwitheicosapentaenoicacidametaanalysisandmetaregressionincludingthestrengthtrial |